Authors: Argentini, M Barboule, N Wasylyk, B

Citation: M. Argentini et al., The contribution of the acidic domain of MDM2 to p53 and MDM2 stability, ONCOGENE, 20(11), 2001, pp. 1267-1275

Authors: Argentini, M Barboule, N Wasylyk, B

Citation: M. Argentini et al., The contribution of the RING finger domain of MDM2 to cell cycle progression, ONCOGENE, 19(34), 2000, pp. 3849-3857

Authors: dos Santos, DF Argentini, M Weinreich, R Hansen, HJ

Citation: Df. Dos Santos et al., Labelling of carbaboranyl compounds with a selenium atom with a view to applications in boron-neutron-capture therapy (BNCT) and positron-emission tomography (PET), HELV CHIM A, 83(11), 2000, pp. 2926-2938

Authors: Gallagher, WM Argentini, M Sierra, V Bracco, L Debussche, L Conseiller, E

Citation: Wm. Gallagher et al., MBP1: a novel mutant p53-specific protein partner with oncogenic properties, ONCOGENE, 18(24), 1999, pp. 3608-3616

Authors: Wasylyk, C Salvi, R Argentini, M Dureuil, C Delumeau, I Abecassis, J Debussche, L Wasylyk, B

Citation: C. Wasylyk et al., p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53, ONCOGENE, 18(11), 1999, pp. 1921-1934